Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Compare retirement index funds to see which has the lowest fees while meeting your risk and diversification goals.
28,038 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Micron Technology jumped on a bold target upgrade, lifting questions about sustainability as the AI memory cycle fuel...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Bitcoin has staged a rebound but faces a pivotal test near mid-$60,000s. This bitcoin price analysis: ready framework...
The Los Angeles Police Department is reworking its agreement with Flock Safety to add tighter privacy safeguards, kee...
Palantir sits around $130 as Michael Burry’s $46 valuation challenge re-emerges, forcing a sharper look at growth, ma...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
A targeted Florida housing bill aims to convert idle Southeast Florida golf courses into housing, triggering lawsuits...
Zcash (ZEC) posts a near-90% jump over the last month, bucking broader market weakness. Analysts debate whether this ...
Amazon’s cloud powerhouse AWS posted its strongest growth in more than three years, as AI infrastructure investments ...
Hershey and Vertex defy a technical warning flag as analysts stay bullish and big funds keep buying, highlighting a s...
AI-driven memory demand pushes prices higher, prompting Apple to raise Mac and iPad prices by roughly 20%. The indust...